BRANDO, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 784
EU - Europa 294
AS - Asia 87
SA - Sud America 5
AF - Africa 2
OC - Oceania 1
Totale 1.173
Nazione #
US - Stati Uniti d'America 778
IT - Italia 166
SG - Singapore 56
DE - Germania 48
GB - Regno Unito 26
FI - Finlandia 13
IE - Irlanda 10
CN - Cina 9
HK - Hong Kong 9
RO - Romania 8
IN - India 7
BE - Belgio 4
MX - Messico 4
PE - Perù 3
RU - Federazione Russa 3
CA - Canada 2
CI - Costa d'Avorio 2
DK - Danimarca 2
FR - Francia 2
GR - Grecia 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
IR - Iran 1
JP - Giappone 1
KZ - Kazakistan 1
LT - Lituania 1
PK - Pakistan 1
TH - Thailandia 1
UA - Ucraina 1
Totale 1.173
Città #
Ashburn 132
Chandler 132
Fairfield 71
Palermo 50
Singapore 46
New York 36
Medford 28
Houston 27
Woodbridge 27
Santa Clara 24
Seattle 23
Rome 20
Wilmington 19
Milan 16
Des Moines 15
Lawrence 15
Ludwigshafen am Rhein 15
Princeton 15
San Diego 14
Altamura 12
Helsinki 11
Ann Arbor 9
Bremen 9
Dublin 9
Kitzingen 9
Cambridge 7
Central 6
London 6
Los Angeles 6
Pune 6
Tappahannock 6
Dallas 5
Padova 5
Beijing 4
Brussels 4
Cagliari 4
Kilburn 4
Santa Catarina 4
Lima 3
Munich 3
Abidjan 2
Athens 2
Chicago 2
Copenhagen 2
Falls Church 2
Foggia 2
Hanover 2
Hong Kong 2
Lappeenranta 2
Marino 2
Mehlingen 2
Mezzojuso 2
New Bedfont 2
Partinico 2
Porto Empedocle 2
Rimini 2
San Paolo di Civitate 2
Sigillo 2
Turin 2
Venice 2
Yangzhou 2
Acton 1
Alcamo 1
Athlone 1
Aversa 1
Bad Bellingen 1
Boardman 1
Buffalo 1
Canberra 1
Chieti 1
Chiswick 1
Conegliano 1
Council Bluffs 1
Dubai 1
Edinburgh 1
Fulham 1
Genoa 1
Guangzhou 1
Hounslow 1
Islamabad 1
Kiev 1
Kowloon 1
Kumar 1
La Châtre 1
Manchester 1
Messina 1
Milazzo 1
Moscow 1
Newark 1
Norfolk 1
Nottingham 1
Olomouc 1
Oral 1
Ottawa 1
Phoenix 1
Prineville 1
Quito 1
Redwood City 1
San Francisco 1
Santiago 1
Totale 938
Nome #
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions 135
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 111
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 100
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming 84
MUTYH-associated tumor syndrome: The other face of MAP 77
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) 65
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes 62
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning 59
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors 58
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome 49
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 48
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? 46
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 44
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one? 43
Prognostic role of plasma pd‐1, pd‐l1, pan‐btn3as and btn3a1 in patients affected by metastatic gastrointestinal stromal tumors: Can immune checkpoints act as a sentinel for short‐term survival? 42
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 38
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength 34
POTENTIAL APPLICATIONS OF LIQUID BIOPSY IN IMMUNOTHERAPY: ROLE OF EXOSOMES, MICRORNAS AND PLASMA EXPRESSION LEVELS OF IMMUNE CHECKPOINTS IN PATIENTS WITH SOLID TUMORS 28
Role of the HIPPO pathway as potential key player in the cross talk between oncology and cardiology 28
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab 27
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 27
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 26
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors 26
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer 19
Liquid biopsy and immunotherapy: is all that glitter gold? 16
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? 14
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 14
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 10
Totale 1.330
Categoria #
all - tutte 9.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 3 51 20 6 18 14 27 5 27
2021/2022202 13 13 3 0 26 7 8 15 14 24 39 40
2022/2023363 28 64 10 48 40 41 16 37 32 4 27 16
2023/2024420 14 31 19 38 22 77 51 53 4 39 18 54
2024/2025174 7 79 81 7 0 0 0 0 0 0 0 0
Totale 1.330